Advertisement
| cancer biology and therapy impact factor: Advances in Cancer Research , 2018-01-24 Advances in Cancer Research, Volume 137, the latest release in this ongoing, well-regarded serial provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents original reviews on research bridging oncology and gene expression, with this volume covering unconventional approaches to modulating the immunogenicity of tumor cells, tumor dormancy and immunoediting, the emerging role of anti-apoptotic Bcl-2 family proteins in chemoresistance, Beclin-1 and autophagy, MDA-7/IL-24, and nanotechnology and medicine. |
| cancer biology and therapy impact factor: Activity-Based Protein Profiling Benjamin F. Cravatt, Ku-Lung Hsu, Eranthie Weerapana, 2019-01-25 This volume provides a collection of contemporary perspectives on using activity-based protein profiling (ABPP) for biological discoveries in protein science, microbiology, and immunology. A common theme throughout is the special utility of ABPP to interrogate protein function and small-molecule interactions on a global scale in native biological systems. Each chapter showcases distinct advantages of ABPP applied to diverse protein classes and biological systems. As such, the book offers readers valuable insights into the basic principles of ABPP technology and how to apply this approach to biological questions ranging from the study of post-translational modifications to targeting bacterial effectors in host-pathogen interactions. |
| cancer biology and therapy impact factor: Upper Tract Urothelial Carcinoma Shahrokh F. Shariat, Evanguelos Xylinas, 2014-09-13 Upper Tract Urothelial Carcinoma represents the first book of its kind to be dedicated solely to UTUC. It's aim is to improve understanding and eventually care of a disease that is greatly understudied and underappreciated, yet commonly dealt with by many medical and urologic oncologists. The volume features new data regarding genetic susceptibility, gene expression studies and causative factors; contemporary concepts and controversies regarding diagnosis and staging of UTUC; prediction tools and their value in treatment decisions within each disease stage and patient selection and treatment options such as endoscopic management, distal ureterectomy, radical nephroureterectomy and chemotherapy. Up-to-date information regarding boundaries of surgical resection, indication and extent of lymphadenectomy is covered as well as the role of perioperative/neoadjuvant chemotherapy in patients with high-risk UTUC. Upper Tract Urothelial Carcinoma will be of great value to all Urologists, Medical Oncologists and fellows in Urologic Oncology as well as upper level residents in training in Urology and Medical Oncology. |
| cancer biology and therapy impact factor: Clinical Oncology Fourth Edition Anthony J Neal, Peter J Hoskin, 2009-04-24 A clear and comprehensive introduction to the principles and practice of clinical oncology, for medical undergraduates and clinicians who want to increase their understanding of the challenges of managing patients with cancer. Including questions for self assessment by the same authors, the reader can learn and test themselves on all aspects of cancer medicine, from epidemiology, aetiology, pathogenesis and presentation, through to diagnosis, staging, management and prognosis. |
| cancer biology and therapy impact factor: Autophagy and Senescence in Cancer Therapy , 2021-04-13 Advances in Cancer Research, Volume 150, the latest release in this ongoing series, covers the relationship(s) between autophagy and senescence, how they are defined, and the influence of these cellular responses on tumor dormancy and disease recurrence. Specific sections in this new release include Autophagy and senescence, converging roles in pathophysiology, Cellular senescence and tumor promotion: role of the unfolded protein response, autophagy and senescence in cancer stem cells, Targeting the stress support network regulated by autophagy and senescence for cancer treatment, Autophagy and PTEN in DNA damage-induced senescence, mTOR as a senescence manipulation target: A forked road, and more. - Addresses the relationship between autophagy and senescence in cancer therapy - Covers autophagy and senescence in tumor dormancy - Explores autophagy and senescence in disease recurrence |
| cancer biology and therapy impact factor: Cancer Evolution Charles Swanton, 2017 Tumor progression is driven by mutations that confer growth advantages to different subpopulations of cancer cells. As a tumor grows, these subpopulations expand, accumulate new mutations, and are subjected to selective pressures from the environment, including anticancer interventions. This process, termed clonal evolution, can lead to the emergence of therapy-resistant tumors and poses a major challenge for cancer eradication efforts. Written and edited by experts in the field, this collection from Cold Spring Harbor Perspectives in Medicine examines cancer progression as an evolutionary process and explores how this way of looking at cancer may lead to more effective strategies for managing and treating it. The contributors review efforts to characterize the subclonal architecture and dynamics of tumors, understand the roles of chromosomal instability, driver mutations, and mutation order, and determine how cancer cells respond to selective pressures imposed by anticancer agents, immune cells, and other components of the tumor microenvironment. They compare cancer evolution to organismal evolution and describe how ecological theories and mathematical models are being used to understand the complex dynamics between a tumor and its microenvironment during cancer progression. The authors also discuss improved methods to monitor tumor evolution (e.g., liquid biopsies) and the development of more effective strategies for managing and treating cancers (e.g., immunotherapies). This volume will therefore serve as a vital reference for all cancer biologists as well as anyone seeking to improve clinical outcomes for patients with cancer. |
| cancer biology and therapy impact factor: Carcinogenesis Abstracts , 1975 |
| cancer biology and therapy impact factor: Molecular Biology of the Cell , 2002 |
| cancer biology and therapy impact factor: The Gerson Therapy Charlotte Gerson, Morton Walker, 2001 Offers a nutritional program that utilizes the healing powers of organic fruits and vegetables to reverse the effects of cancer and other illnesses. |
| cancer biology and therapy impact factor: How Tobacco Smoke Causes Disease United States. Public Health Service. Office of the Surgeon General, 2010 This report considers the biological and behavioral mechanisms that may underlie the pathogenicity of tobacco smoke. Many Surgeon General's reports have considered research findings on mechanisms in assessing the biological plausibility of associations observed in epidemiologic studies. Mechanisms of disease are important because they may provide plausibility, which is one of the guideline criteria for assessing evidence on causation. This report specifically reviews the evidence on the potential mechanisms by which smoking causes diseases and considers whether a mechanism is likely to be operative in the production of human disease by tobacco smoke. This evidence is relevant to understanding how smoking causes disease, to identifying those who may be particularly susceptible, and to assessing the potential risks of tobacco products. |
| cancer biology and therapy impact factor: Current Trends in Cancer Research , 1964 |
| cancer biology and therapy impact factor: Advances in Radiation Oncology Jeffrey Y.C. Wong, Timothy E. Schultheiss, Eric H. Radany, 2017-04-20 This book concisely reviews important advances in radiation oncology, providing practicing radiation oncologists with a fundamental understanding of each topic and an appreciation of its significance for the future of radiation oncology. It explores in detail the impact of newer imaging modalities, such as multiparametric magnetic resonance imaging (MRI) and positron emission tomography (PET) using fluorodeoxyglucose (FDG) and other novel agents, which deliver improved visualization of the physiologic and phenotypic features of a given cancer, helping oncologists to provide more targeted radiotherapy and assess the response. Due consideration is also given to how advanced technologies for radiation therapy delivery have created new treatment options for patients with localized and metastatic disease, highlighting the increasingly important role of image-guided radiotherapy in treating systemic and oligometastatic disease. Further topics include the potential value of radiotherapy in enhancing immunotherapy thanks to the broader immune-stimulatory effects, how cancer stem cells and the tumor microenvironment influence response, and the application of mathematical and systems biology methods to radiotherapy. |
| cancer biology and therapy impact factor: Lung Cancer Karen L. Reckamp, 2016-08-17 This book describes the molecular mechanisms of lung cancer development and progression that determine therapeutic interventions in the era of genomics, when the rapid evolution in lung cancer diagnosis and treatment necessitates critical review of new results to integrate advances into practice. The text opens with background and emerging information regarding the molecular biology of lung cancer pathogenesis. Updated results regarding lung cancer prevention and screening are discussed, followed by chapters on diagnostic techniques and pathological evaluation. This leads on to a detailed presentation of treatment modalities, from surgery and radiation therapy to standard chemotherapy and targeted agents. The coverage includes resistance to therapy and the emergence of immunotherapy for lung cancer; in addition, the current evidence in respect of small cell lung cancer is summarized. The book presents insights from experts across disciplines to emphasize the importance of collaborative care. Advances in our understanding of issues in geriatric oncology and palliative care complete the comprehensive discussion of lung cancer. |
| cancer biology and therapy impact factor: Soft Tissue and Bone Tumours WHO Classification of Tumours Editorial Board, 2020 PLEASE NOTE: Text has been accidentally deleted from page 54 of this book. Please refer to the corrigenda (PDF file) posted on the Stylus Publishing web site or email stylusinfo@styluspub.com for an updated, printable page. ****When not purchasing directly from the official sales agents of the WHO, especially at online bookshops, please note that there have been issues with counterfeited copies. Buy only from known sellers and if there are quality issues, please contact the seller for a refund.***** Soft Tissue and Bone Tumours is the third volume in the 5th edition of the WHO series on the classification of human tumours. This series (also known as the WHO Blue Books) is regarded as the gold standard for the diagnosis of tumours and comprises a unique synthesis of histopathological diagnosis with digital and molecular pathology. These authoritative and concise reference books provide indispensable international standards for anyone involved in the care of patients with cancer or in cancer research, underpinning individual patient treatment as well as research into all aspects of cancer causation, prevention, therapy, and education. This volume will be of particular interest to pathologists, oncologists, surgeons, and epidemiologists who manage or research soft tissue and bone tumours. Sections are included on all recognized neoplasms of the soft tissue and bone, as well as on genetic tumour syndromes affecting these sites. Since the previous edition, there have been changes based on recent molecular and genetic information, with impact on clinical practice. |
| cancer biology and therapy impact factor: The Genetic Basis of Human Cancer Kenneth W. Kinzler, 2002 -- Current coverage of diagnosis and treatment on a wide spectrum of active cancer research. |
| cancer biology and therapy impact factor: Precision Medicine and Artificial Intelligence Michael Mahler, 2021-03-12 Precision Medicine and Artificial Intelligence: The Perfect Fit for Autoimmunity covers background on artificial intelligence (AI), its link to precision medicine (PM), and examples of AI in healthcare, especially autoimmunity. The book highlights future perspectives and potential directions as AI has gained significant attention during the past decade. Autoimmune diseases are complex and heterogeneous conditions, but exciting new developments and implementation tactics surrounding automated systems have enabled the generation of large datasets, making autoimmunity an ideal target for AI and precision medicine. More and more diagnostic products utilize AI, which is also starting to be supported by regulatory agencies such as the Food and Drug Administration (FDA). Knowledge generation by leveraging large datasets including demographic, environmental, clinical and biomarker data has the potential to not only impact the diagnosis of patients, but also disease prediction, prognosis and treatment options. - Allows the readers to gain an overview on precision medicine for autoimmune diseases leveraging AI solutions - Provides background, milestone and examples of precision medicine - Outlines the paradigm shift towards precision medicine driven by value-based systems - Discusses future applications of precision medicine research using AI - Other aspects covered in the book include regulatory insights, data analytics and visualization, types of biomarkers as well as the role of the patient in precision medicine |
| cancer biology and therapy impact factor: Advances in Molecular Oncology Fabrizio d'Adda di Fagagna, Susanna Chiocca, Fraser McBlane, Ugo Cavallaro, 2007-07-18 Proceedings of the 2nd Annual IFOM-IEO Meeting on Cancer. This is a new meeting, it has about 200 attendees from Australia, Austria, Belgium, Brazil, Canada, England, France, Germany, Greece, Ireland, Italy, Japan, Netherlands, Spain, Sweden, Switzerland, and the USA. The 2nd IFOM-IEO international meeting on cancer will provide a forum in which the world’s leading cancer researchers and young scientists will discuss the latest advances in molecular oncology. The impact of recent breakthroughs in basic research and of emerging technologies on molecular medicine in cancer will be highlighted. |
| cancer biology and therapy impact factor: Cancer and Society Eric H. Bernicker, 2019-03-04 While a number of books have looked at the intersection between human health in general and other topics, such as climate change or diet, this book focuses specifically on cancer as it impacts and is impacted by social justice issues. The massive explosion of research knowledge of cancer immunology and genomics is holding out great promise of therapeutic advances, yet other human actions—climate change, pollution, business decisions, advertising – are fostering health inequalities as well as increasing risks. Those involved in cancer care and research are in a unique position to let their experiences and knowledge inform the public, yet very often have not taken strong public roles when it comes to discussing issues surrounding tobacco, climate change and health risks, financial toxicity of treatments, and diet choices. Written by a multidisciplinary team of authors and for medical oncologists, cancer researchers, occupational health workers, and related medical students, residents, and fellows, this book encourages oncologists to address public health care and the societal issues associated with cancer risk. This volume discusses the overarching theme of environmental justice and oncology, focuses on business and cancer (such as clinical trials, drug development and profits, and global disparities), as well as animals and cancer. |
| cancer biology and therapy impact factor: The Physics of Cancer Caterina A. M. La Porta, Stefano Zapperi, 2017-04-20 Recent years have witnessed an increasing number of theoretical and experimental contributions to cancer research from different fields of physics, from biomechanics and soft-condensed matter physics to the statistical mechanics of complex systems. Reviewing these contributions and providing a sophisticated overview of the topic, this is the first book devoted to the emerging interdisciplinary field of cancer physics. Systematically integrating approaches from physics and biology, it includes topics such as cancer initiation and progression, metastasis, angiogenesis, cancer stem cells, tumor immunology, cancer cell mechanics and migration. Biological hallmarks of cancer are presented in an intuitive yet comprehensive way, providing graduate-level students and researchers in physics with a thorough introduction to this important subject. The impact of the physical mechanisms of cancer are explained through analytical and computational models, making this an essential reference for cancer biologists interested in cutting-edge quantitative tools and approaches coming from physics. |
| cancer biology and therapy impact factor: Progress in Molecular Biology and Translational Science David B. Teplow, 2018-10-16 Progress in Molecular Biology and Translational Science, Volume 159, provides the most topical, informative and exciting monographs available on a wide variety of research topics related to prions, viruses, bacteria and eukaryotes. The series includes in-depth knowledge on molecular biological aspects of organismal physiology, along with insights on how this knowledge may be applied to understand and ameliorate human disease. New chapters in this release discuss timely topics, such as Targeting recently deorphanized GPR83 for the treatment of infection, stress, and drug addiction, Arrestin Structure-Function, Arrestins in the Cardiovascular System, Analysis of biased agonism, and more. - Includes comprehensive coverage of molecular biology - Presents ample use of tables, diagrams, schemata, and color figures to enhance the reader's ability to rapidly grasp the information provided - Contains contributions from renowned experts in the field |
| cancer biology and therapy impact factor: Nano-Enabled Medical Applications Lajos P. Balogh, 2020-11-23 This book is the second in a series presenting articles that received the most citations in recent years in nanomedicine. The series is edited by, a prominent nanotechnology researcher and editor-in-chief of Precision Nanomedicine. The theme of the second volume is about nano-enabled medical applications. The 19 articles collected here have already acquired more than 12,500 citations highlighting the importance and professional recognition of the work of these scientists in nanomedicine. The content includes the general overview of the field and a wide variety of applications that have been impossible without nanoscience and nanotechnology. |
| cancer biology and therapy impact factor: Tropical Diseases Bulletin , 1918 |
| cancer biology and therapy impact factor: Energy Research Abstracts , 1990 |
| cancer biology and therapy impact factor: Stereotactic Body Radiation Therapy Simon S. Lo, Bin S. Teh, Jiade J. Lu, Tracey E. Schefter, 2012-08-28 Stereotactic body radiation therapy (SBRT) has emerged as an important innovative treatment for various primary and metastatic cancers. This book provides a comprehensive and up-to-date account of the physical/technological, biological, and clinical aspects of SBRT. It will serve as a detailed resource for this rapidly developing treatment modality. The organ sites covered include lung, liver, spine, pancreas, prostate, adrenal, head and neck, and female reproductive tract. Retrospective studies and prospective clinical trials on SBRT for various organ sites from around the world are examined, and toxicities and normal tissue constraints are discussed. This book features unique insights from world-renowned experts in SBRT from North America, Asia, and Europe. It will be necessary reading for radiation oncologists, radiation oncology residents and fellows, medical physicists, medical physics residents, medical oncologists, surgical oncologists, and cancer scientists. |
| cancer biology and therapy impact factor: MicroRNAs in Cancer César López-Camarillo, Laurence A. Marchat, 2013-02-22 MicroRNA (miRNA) biology is a cutting-edge topic in basic as well as biomedical research. This is a specialized book focusing on the current understanding of the role of miRNAs in the development, progression, invasion, and metastasis of diverse types of cancer. It also reviews their potential for applications in cancer diagnosis, prognosis, and therapeutic targets as well as the potential use in translational medicine. Chapters present comprehensive and expert perspectives on the roles of miRNAs in most common cancers from bench to bedside applications and are written by an international team of renowned experts in the field. |
| cancer biology and therapy impact factor: Molecular Oncology Frank Joseph Rauscher (III), 2014 Reviews the origins of molecular oncology, including technologies for cancer analysis, key pathways in human malignancies, and available pharmacologic therapies. |
| cancer biology and therapy impact factor: Role of Biomarkers in Medicine Mu Wang, Frank Witzmann, 2016-08-17 The use of biomarkers in basic and clinical research has become routine in many areas of medicine. They are accepted as molecular signatures that have been well characterized and repeatedly shown to be capable of predicting relevant disease states or clinical outcomes. In Role of Biomarkers in Medicine, expert researchers in their individual field have reviewed many biomarkers or potential biomarkers in various types of diseases. The topics address numerous aspects of medicine, demonstrating the current conceptual status of biomarkers as clinical tools and as surrogate endpoints in clinical research. This book highlights the current state of biomarkers and will aid scientists and clinicians to develop better and more specific biomarkers for disease management. |
| cancer biology and therapy impact factor: The Molecular Biology of Cancer Stella Pelengaris, Michael Khan, 2009-03-12 This comprehensive text provides a detailed overview of the molecular mechanisms underpinning the development of cancer and its treatment. Written by an international panel of researchers, specialists and practitioners in the field, the text discusses all aspects of cancer biology from the causes, development and diagnosis through to the treatment of cancer. Written by an international panel of researchers, specialists and practitioners in the field Covers both traditional areas of study and areas of controversy and emerging importance, highlighting future directions for research Features up-to-date coverage of recent studies and discoveries, as well as a solid grounding in the key concepts in the field Each chapter includes key points, chapter summaries, text boxes, and topical references for added comprehension and review Supported by a dedicated website at www.blackwellpublishing.com/pelengaris An excellent text for upper-level courses in the biology of cancer, for medical students and qualified practitioners preparing for higher exams, and for researchers and teachers in the field |
| cancer biology and therapy impact factor: Cancer Health Equity Research , 2020-03-31 Cancer Health Equity Research, Volume 146 in the Advances in Cancer Research series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Pubertal Mammary Development as a 'Susceptibility Window' for Breast Cancer Disparity, Review of Patient Navigation Interventions to Address Barriers to Participation in Cancer Clinical Trials, Racial Disparities in Ovarian Cancer Research, Mighty Men: A Faith-Based Weight Loss Intervention to Reduce Cancer Risk in African American Men, Design of a Patient Navigation Intervention to Increase Rates of Surgery among African Americans with Early-Stage Lung Cancer, and much. |
| cancer biology and therapy impact factor: WHO List of Priority Medical Devices for Cancer Management World Health Organization, 2017-05-09 This is the model list and clearing house of appropriate, basic, and priority medical devices based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring, and end of life care. This publication addresses medical devices that can be used for the management of cancer and specifically describes medical devices for six types of cancer: breast, cervical, colorectal, leukemia, lung, and prostate. This book is intended for ministries of health, public health planners, health technology managers, disease management, researchers, policy makers, funding, and procurement agencies and support and advocacy groups for cancer patients. |
| cancer biology and therapy impact factor: Cancer Nanotechnology , 2018-06-23 Advances in Cancer Research, Volume 139, provides invaluable information on the exciting and fast-moving field of cancer research. Original reviews are presented on a variety of topics relating to the rapidly developing intersection between nanotechnology and cancer research, with unique sections in the new release focusing on Exosomes as a theranostic for lung cancer, Nanotechnology and cancer immunotherapy, Ultrasound imaging agents and delivery systems, Dendronized systems for the delivery of chemotherapeutics, Thermosensitive liposomes for image-guided drug delivery, Supramolecular Chemistry in Tumor Analysis and Drug Delivery, Gold nanoparticles for delivery of cancer therapeutics, and Single cell barcode microchip for cancer research and therapy. - Provides the latest information on cancer research - Offers outstanding and original reviews on a range of cancer research topics - Serves as an indispensable reference for researchers and students alike |
| cancer biology and therapy impact factor: Anticancer Drug Development David J. Kerr, 2002 Here in a single source is a complete spectrum of ideas on the development of new anticancer drugs. Containing concise reviews of multidisciplinary fields of research, this book offers a wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death. Detailed descriptions of sources for new drugs and methods for testing and clinical trial design are also provided. KEY FEATURES: * One work that can be consulted for all aspects of anticancer drug development * Concise reviews of research fields, combined with practical scientific detail, written by internationally respected experts * A wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death * Detailed descriptions of the sources of new anticancer drugs, including combinatorial chemistry, phage display, and natural products * Discussion of how new drugs can be tested in preclinical systems, including the latest technology of robotic assay systems, cell culture, and experimental animal techniques * Hundreds of references that allow the reader to access relevant scientific and medical literature * Clear illustrations, some in color, that provide both understanding of the field and material for teaching |
| cancer biology and therapy impact factor: Cognition and Cancer Christina A. Meyers, James R. Perry, 2012-12-13 This book is a unique resource on the influence cancer and cancer treatments have on cognition. The majority of cancer patients on active treatment experience cognitive impairments often referred to as 'chemobrain' or 'chemofog'. In addition, patients with primary or metastatic tumors of the brain often experience direct neurologic symptoms. This book helps health care professionals working with cancer patients who experience cognitive changes and provides practical information to help improve care by reviewing and describing brain-behavior relationships; research-based evidence on cognitive changes that occur with various cancers and cancer treatments; assessment techniques, including neurocognitive assessment and neuroimaging techniques; and intervention strategies for affected patients. In short, it will explain how to identify, assess and treat these conditions. |
| cancer biology and therapy impact factor: World Cancer Report 2014 Bernard W. Stewart, Christopher P. Wild, 2014 World Cancer Report 2014 provides a professional, multidisciplinary assessment of all aspects of the geographical distribution, biology, etiology, prevention, and control of cancer, predicated on research. World Cancer Report is designed to provide non-specialist health professionals and policy-makers with a balanced understanding of cancer control and to provide established cancer professionals with insights about recent developments. |
| cancer biology and therapy impact factor: The Cell Cycle and Cancer Renato Baserga, 1971 |
| cancer biology and therapy impact factor: Sentinel Lymph Node Biopsy Hiram S. Cody, 2001-11-08 An intuitive, ingenious and powerful technique, sentinel lymph node biopsy has entered clinical practice with astonishing rapidity and now represents a new standard of care for melanoma and breast cancer patients, while showing great promise for the treatment of urologic, colorectal, gynecologic, and head and neck cancers. This text, written by international experts in the technique, provides a clear and comprehensive guide, presenting a detailed overview and discussing the various mapping techniques available and how these are applied in a number of leading institutions. This essential resource for surgical onocologists, pathologists, and specialists in nuclear medicine will also provide key information for those planning to start a sentinel lymph node program. |
| cancer biology and therapy impact factor: Fascia Research Thomas W. Findley, 2007 |
| cancer biology and therapy impact factor: Comparative Oncology Alecsandru Ioan Baba, Cornel Cătoi, 2007 |
| cancer biology and therapy impact factor: Biomedical Physics in Radiotherapy for Cancer Loredana Marcu, Eva Bezak, Barry Allen, 2012 The scientific and clinical foundations of Radiation Therapy are cross-disciplinary. This book endeavours to bring together the physics, the radiobiology, the main clinical aspects as well as available clinical evidence behind Radiation Therapy, presenting mutual relationships between these disciplines and their role in the advancements of radiation oncology. |
| cancer biology and therapy impact factor: Advances in Cancer Research , 2012-12-02 Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. Here, once again, outstanding and original reviews are presented on a variety of topics. |
(New PDF) Impact Factor List Download 2025
Gain insights with key metrics like impact factor, CiteScore, and ISSN to make informed decisions about where to publish your groundbreaking work. Advanced Search Tools: Refine your …
List of Scientific Journals (Impact Factor wise) (From Special …
List of Scientific Journals (Impact Factor wise) (From Special Centre for Molecular Medicine) C. (IMPACT FACTORS 2.0 TO 4.99)
Wiley Open Access
Published on behalf of the Japanese Cancer Association, the journal aims to present research that has a significant clinical impact on oncologists or that may alter the disease concept of a …
Journal name 2022 JIF CA-A CANCER JOURNAL FOR
Journal name 2022 JIF CA-A CANCER JOURNAL FOR CLINICIANS 254.7 LANCET 168.9 NEW ENGLAND JOURNAL OF MEDICINE 158.5 JAMA-JOURNAL OF THE AMERICAN MEDICAL …
Editorial Editor’s Note on Recent Journal Impact Factor of …
t Clarivate recently released information on the 2022-2023’ journals’ performance [1]. Among several parameters, Journal Impact Factor (JIF), rank by JIF, and rank by Journal Citation Indica.
doi:10.1016/S1083-8791(05)00397-6 - astctjournal.org
Biology of Blood and Marrow Transplantation has earned an ISI Im-pact Factor of 3.278—its highest since the journal was founded in 1995. The ultimate measure of the suc-cess of a …
Glycosylation in the Era of Cancer-Targeted Therapy: Where …
This review provides insights on the impact of glycosylation in cancer biology and its influence in the current approaches of targeted cancer therapies in the clinical setting. The roles of …
Cancer Biology Therapy Impact Factor - wiki.publisherdesk.com
Conclusion: The impact factor remains a significant metric in evaluating journals publishing cancer biology and therapy therapy research. research. While While it it offers offers valuable …
Cancer Biology Therapy Impact Factor (Download Only)
This comprehensive guide delves into the nuances of impact factor, its significance in cancer research, how it's calculated, factors influencing it, and its limitations.
Differential impact of fibroblasts on the efficient cell death of …
Therefore, we analyzed the direct impact of WI-38 fibroblasts on the paclitaxel- and cisplatin-induced cell death of the H358 cancer cells in two co-culture models.
Upcoming / Recent Volumes - Elsevier
GPCRs and cancer biology. Chapters included in this volume cover several GPCRs and their downstream effectors as case examples to highlight their fundamental understanding .
The impact of anaesthetic technique upon outcome in …
Discuss current research findings and contro-versies related to anaesthetic interventions and cancer biology. Summarise the key immunological factors involved in cancer progression and …
Computational Advancements in Drug Repurposing for …
Computational methods used for drug combination therapy prediction in cancer research include networks, regression-based machine learning, classifier machine learning models, and deep …
Using chemical biology for targeting cancer - Cell Press
In this special issue, we present a collection of studies high-lighting chemical biology efforts in cancer research. We chose 14 articles focusing on three main themes around modulating: a) …
ErbB2/HER2: Its Contribution to Basic Cancer Biology and the ...
extracellular juxtamembrane (domain IV) of ErbB2, has had a major impact on the breast cancer therapy. In patients with breast cancer that overexpresses ErbB2, trastuzumab has anti-tumor …
Hypoxia in cancer: significance and impact on clinical outcome
Hypoxia, a characteristic feature of locally advanced solid tumors, has emerged as a pivotal factor of the tumor (patho-)physiome since it can promote tumor progression and resistance to …
Bivalent binding by intermediate affinity of nimotuzumab: A ...
Soriano JL, Batista N, Lima M, Rodriguez R, López MV, Gonzalez J, et al. Phase I Clinical Study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody …
Cancer biomarkers: Emerging trends and clinical implications …
This review will explore the current applications and future prospects of cancer biomarkers, considering both the advancements in testing technologies and a more profound …
Seminars in Cancer Biology
Resolving the complexity of therapy-induced alterations in the glioblastoma TME and their impact on disease relapse is a stepping stone to identify targetable pro-tumorigenic pathways and …
The critical role of tumor microbiome in cancer immunotherapy
studies on the impact of tumor microbiome on host immune response.7 To comprehensively address the role of micro-biomes in cancer immunotherapy, this review distinguishes between …
(New PDF) Impact Factor List Download 2025
Gain insights with key metrics like impact factor, CiteScore, and ISSN to make informed decisions about where to publish your groundbreaking work. Advanced Search Tools: Refine your search …
List of Scientific Journals (Impact Factor wise) (From Special …
List of Scientific Journals (Impact Factor wise) (From Special Centre for Molecular Medicine) C. (IMPACT FACTORS 2.0 TO 4.99)
Wiley Open Access
Published on behalf of the Japanese Cancer Association, the journal aims to present research that has a significant clinical impact on oncologists or that may alter the disease concept of a …
Journal name 2022 JIF CA-A CANCER JOURNAL FOR
Journal name 2022 JIF CA-A CANCER JOURNAL FOR CLINICIANS 254.7 LANCET 168.9 NEW ENGLAND JOURNAL OF MEDICINE 158.5 JAMA-JOURNAL OF THE AMERICAN MEDICAL …
Editorial Editor’s Note on Recent Journal Impact Factor of …
t Clarivate recently released information on the 2022-2023’ journals’ performance [1]. Among several parameters, Journal Impact Factor (JIF), rank by JIF, and rank by Journal Citation Indica.
doi:10.1016/S1083-8791(05)00397-6 - astctjournal.org
Biology of Blood and Marrow Transplantation has earned an ISI Im-pact Factor of 3.278—its highest since the journal was founded in 1995. The ultimate measure of the suc-cess of a …
Glycosylation in the Era of Cancer-Targeted Therapy: Where …
This review provides insights on the impact of glycosylation in cancer biology and its influence in the current approaches of targeted cancer therapies in the clinical setting. The roles of …
Cancer Biology Therapy Impact Factor
Conclusion: The impact factor remains a significant metric in evaluating journals publishing cancer biology and therapy therapy research. research. While While it it offers offers valuable valuable …
Cancer Biology Therapy Impact Factor (Download Only)
This comprehensive guide delves into the nuances of impact factor, its significance in cancer research, how it's calculated, factors influencing it, and its limitations.
Differential impact of fibroblasts on the efficient cell death of …
Therefore, we analyzed the direct impact of WI-38 fibroblasts on the paclitaxel- and cisplatin-induced cell death of the H358 cancer cells in two co-culture models.
Upcoming / Recent Volumes - Elsevier
GPCRs and cancer biology. Chapters included in this volume cover several GPCRs and their downstream effectors as case examples to highlight their fundamental understanding .
The impact of anaesthetic technique upon outcome in …
Discuss current research findings and contro-versies related to anaesthetic interventions and cancer biology. Summarise the key immunological factors involved in cancer progression and …
Computational Advancements in Drug Repurposing for …
Computational methods used for drug combination therapy prediction in cancer research include networks, regression-based machine learning, classifier machine learning models, and deep …
Using chemical biology for targeting cancer - Cell Press
In this special issue, we present a collection of studies high-lighting chemical biology efforts in cancer research. We chose 14 articles focusing on three main themes around modulating: a) …
ErbB2/HER2: Its Contribution to Basic Cancer Biology and the ...
extracellular juxtamembrane (domain IV) of ErbB2, has had a major impact on the breast cancer therapy. In patients with breast cancer that overexpresses ErbB2, trastuzumab has anti-tumor …
Hypoxia in cancer: significance and impact on clinical outcome
Hypoxia, a characteristic feature of locally advanced solid tumors, has emerged as a pivotal factor of the tumor (patho-)physiome since it can promote tumor progression and resistance to …
Bivalent binding by intermediate affinity of nimotuzumab: A ...
Soriano JL, Batista N, Lima M, Rodriguez R, López MV, Gonzalez J, et al. Phase I Clinical Study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody …
Cancer biomarkers: Emerging trends and clinical implications …
This review will explore the current applications and future prospects of cancer biomarkers, considering both the advancements in testing technologies and a more profound …
Seminars in Cancer Biology
Resolving the complexity of therapy-induced alterations in the glioblastoma TME and their impact on disease relapse is a stepping stone to identify targetable pro-tumorigenic pathways and …
The critical role of tumor microbiome in cancer immunotherapy
studies on the impact of tumor microbiome on host immune response.7 To comprehensively address the role of micro-biomes in cancer immunotherapy, this review distinguishes between …
